EPIZYME, INC. Assets, Fair Value Disclosure
EPIZYME, INC. had Assets, Fair Value Disclosure of $284.07 million as of 2019-09-30, per its 10-Q filed 2019-10-31.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:AssetsFairValueDisclosure · last filed 2019-10-31
- 2019-09-30: Assets, Fair Value Disclosure $284.07M.
- 2019-06-30: Assets, Fair Value Disclosure $322.12M.
- 2019-03-31: Assets, Fair Value Disclosure $364.80M.
- 2018-12-31: Assets, Fair Value Disclosure $232.86M.
| Period end | Assets, Fair Value Disclosure |
|---|---|
| 2019-09-30 | $284.07M 10-Q · filed 2019-10-31 |
| 2019-06-30 | $322.12M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $364.80M 10-Q · filed 2019-05-06 |
| 2018-12-31 | $232.86M 10-Q · filed 2019-10-31 |
| 2018-09-30 | $174.74M 10-Q · filed 2018-11-02 |
| 2017-12-31 | $257.03M 10-Q · filed 2018-11-02 |